Li, G., Xian, S., Cheng, X., Hou, Y., Jia, W., & Ma, Y. Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Guangzhuang, Sentao Xian, Xianchao Cheng, Yunhua Hou, Wenqing Jia, and Yukui Ma. Corrigendum: Efficacy of Oroxylin A in Ameliorating Renal Fibrosis with Emphasis on Sirt1 Activation and TGF-β/Smad3 Pathway Modulation. Frontiers Media S.A.
MLA (9th ed.) CitationLi, Guangzhuang, et al. Corrigendum: Efficacy of Oroxylin A in Ameliorating Renal Fibrosis with Emphasis on Sirt1 Activation and TGF-β/Smad3 Pathway Modulation. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.